https://pharmoniq.com/news/pfizer-650m-groton-clinical-manufacturing-plant PharmoniQ en 2026-11-09T14:02:47.301Z Pfizer Plans $650M Groton Plant to Make Drugs for Its Own Trials Pfizer, manufacturing, Connecticut, clinical trials https://pharmoniq.com/news/vir-hepatitis-delta-combo-phase-3-eclipse-1-results PharmoniQ en 2026-11-09T08:01:29.091Z Vir's Hepatitis Delta Combo Leaves Virus Undetectable in 79% Vir Biotechnology, hepatitis delta, phase 3, liver disease, antivirals https://pharmoniq.com/news/boehringer-sino-biopharm-six-cancer-programs-358m-7b-deal PharmoniQ en 2026-11-08T14:02:37.680Z Boehringer Pledges $358M, Up to $7B More, for 6 Sino Cancer Programs Boehringer Ingelheim, Sino Biopharmaceutical, licensing, antibody-drug conjugates, China biotech https://pharmoniq.com/news/agios-cuts-over-100-rd-roles-fda-delays-sickle-cell-ruling PharmoniQ en 2026-11-08T08:03:06.757Z Agios Cuts Over 100 R&D Roles While FDA Delays Sickle Cell Ruling Agios, layoffs, mitapivat, sickle cell disease, FDA https://pharmoniq.com/blog/why-drugmakers-sell-plants-to-cdmos PharmoniQ en 2026-11-09T11:02:38.148Z Why Drugmakers Are Selling Plants to Contract Manufacturers CDMO, contract manufacturing, pharmaceutical manufacturing, mergers and acquisitions, biologics